Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × tenalisib × Clear all

NCT03711604 2024-05-08

Compassionate Use Study of Tenalisib (RP6530)

Phase 1/2 Completed

17 enrolled 9 charts

Other hematologic neoplasm

Hematologic Neoplasms